T
PFE icon

Tidemark’s Pfizer PFE Stock Holding History

Tidemark’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.7K Buy
2,521
+29
+1% +$759 0.01% 284
2026
Q1 		$70K Buy
2,492
+509
+26% +$13.6K 0.02% 231
2025
Q4 		$49.4K Sell
1,983
-951
-32% -$24K 0.01% 242
2025
Q3 		$74.8K Sell
2,934
-258
-8% -$6.37K 0.02% 206
2025
Q2 		$77.4K Buy
3,192
+51
+2% +$1.19K 0.02% 195
2025
Q1 		$79.6K Buy
3,141
+113
+4% +$2.96K 0.03% 191
2024
Q4 		$80.3K Buy
3,028
+154
+5% +$4.18K 0.03% 187
2024
Q3 		$83.2K Sell
2,874
-1,371
-32% -$40K 0.03% 174
2024
Q2 		$119K Buy
4,245
+233
+6% +$6.42K 0.05% 140
2024
Q1 		$111K Sell
4,012
-74
-2% -$2.05K 0.06% 160
2023
Q4 		$118K Buy
+4,086
New +$124K 0.07% 147

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tidemark's PFE Position: Q2 2026 in Review

Tidemark increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $759 and bringing the position to 2,521 shares worth $60.7K. The position accounts for 0.01% of the portfolio, ranked #284.

Tidemark first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $119K in Q2 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tidemark held 2,521 shares of Pfizer worth $60.7K as of Q2 2026.
  • Tidemark bought 29 Pfizer shares in Q2 2026, an estimated $759.
  • Pfizer made up 0.01% of Tidemark's portfolio in Q2 2026, its #284 holding.
  • Tidemark first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Pfizer position peaked at $119K in Q2 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.